SHAREHOLDER ALERT: Weiss Law Investigates Ocean Bio-Chem, Inc.

NEW YORK, June 22, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ocean Bio-Chem, Inc. ("Ocean Bio" or the "Company") (NASDAQ: OBCI), in connection with the proposed acquisition of the Company and its affiliate, Star Brite Europe, Inc., by OneWater Marine Inc. (NASDAQ: ONEW). Under the terms of the merger agreement, the Company's shareholders will receive $13.08 in cash for each share of Ocean Bio common stock owned. The transaction is valued at approximately $125 million.

If you own Ocean Bio shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

https://www.weisslaw.co/news-and-cases/obci
Or please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7^th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Weiss Law is investigating whether (i) Ocean Bio's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $13.08 per-share merger consideration adequately compensates Ocean Bio's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. 

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

SOURCE Weiss Law